Whether persistence of mutations in other genes in age-related CH, such as JAK2, SF3B1, SRSF2, PPM1D, CBL, IDH1 and IDH2, are associated with an increased relapse risk is currently unknown due to the relative low incidence of these mutations in AML. Here, IDH1 is linked to acute myeloid leukemia.